| Incidence and Outcome of Breast Sarcomas in England (2013–2018): An analysis from the National Cancer Registration and Analysis Service | | 2022 |
| Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment | | 2022 |
| Lymphedema therapy referral is associated with improved understanding of lymphedema prevention among breast cancer survivors | | |
| A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting | | |
| Impact of postmastectomy radiation therapy on breast cancer patients according to pathologic nodal status after modern neoadjuvant chemotherapy | | |
| Patterns of Care and Utilization of Radiation for Women With Good-Risk Ductal Carcinoma In Situ: A National Cancer Database Analysis | | 2022 |
| Survival benefits of primary tumor surgery for synchronous brain metastases: A SEER ‐based population study with propensity‐matched comparative analysis | | |
| Reducing rates of chronic breast cancer–related lymphedema with screening and early intervention: an update of recent data | | |
| Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA | | |
| Serum 25-hydroxyvitamin D and cancer-related fatigue: associations and effects on depression, anxiety, functional capacity and health-related quality of Life in breast cancer survivors during adjuvant endocrine therapy | | 2022 |
| ASO Author Reflections: Surgical De-escalation for the Management of Ipsilateral Breast Cancer Recurrence in the Modern Era of Multimodality Treatment | | |
| Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery | | |
| Modern Management of Chest Wall Recurrences after Mastectomy | | |
| Radiation Therapy With Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study | | 2022 |
| De-escalating Surgery Among Patients with HER2 + and Triple Negative Breast Cancer | | |
| Prognostic factors in patients with primary operable breast cancer (cT1-2N0-1M0) after reconstructive plastic surgery with single-stage reconstruction using endoprosthesis | | 2022 |
| Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018 | Breast Cancer Research and Treatment | |
| Tearing down the barriers to exercise after mastectomy: a qualitative inquiry to facilitate exercise among breast cancer survivors | BMJ Open | 2022 |
| Near-maximum rib dose is the most relevant risk factor for ipsilateral spontaneous rib fracture: a dosimetric analysis of breast cancer patients after radiotherapy | Strahlentherapie Und Onkologie | |
| Locoregional Management of Breast Cancer Following Neoadjuvant Chemotherapy | Current Breast Cancer Reports | |
| The Protective Effects of Influenza Vaccination in Elderly Patients with Breast Cancer in Taiwan: A Real-World Evidence-Based Study | Vaccines | 2022 |
| Male Breast Cancer Patient and Surgeon Experience: The Male WhySurg Study | Annals of Surgical Oncology | |
| Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients | Annals of Surgical Oncology | |
| A Critical Overview of Predictors of Heart Sparing by Deep-Inspiration-Breath-Hold Irradiation in Left-Sided Breast Cancer Patients | Cancers | 2022 |
| Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery? | Annals of Surgical Oncology | |
| Clinical Significance of Radiologically Detected Small Indeterminate Extra-Mammary Lesions in Breast Cancer Patients | The Journal of Breast Health | 2022 |
| Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement | Annals of Surgical Oncology | |
| Is there a window of opportunity to optimize trastuzumab cardiac monitoring? | World Journal of Cardiology | 2022 |
| UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer | Clinical and Translational Medicine | 2022 |
| Margin Management and Adjuvant Therapy for Phyllodes Tumors: Practice Patterns of the American Society of Breast Surgeons Members | Annals of Surgical Oncology | |
| Sentinel Lymph Node Biopsy by Lymphatic Flare Technique: a Feasibility Study—“The FLAIR Is in the FLARE” | Indian Journal of Surgical Oncology | |
| A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence | Annals of Surgical Oncology | |
| Usefulness of Hounsfield Units and the Serum Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Patients with Breast Cancer | Cancers | 2022 |
| Comparing oncoplastic breast reduction with immediate symmetry surgery to standard breast reduction surgery: Are postoperative complications worse? | Journal of Surgical Oncology | |
| Chest wall resection for breast cancer: 21st century Mayo clinic experience | Journal of Surgical Oncology | |
| Post-mastectomy radiotherapy bolus associated complications in patients who underwent two-stage breast reconstruction | Advances in Radiation Oncology | 2022 |
| Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer | Annals of Surgical Oncology | |
| Immunotherapy for triple negative breast cancer: How can pathologic responses to experimental drugs in early-stage disease be enhanced? | Expert Opinion on Investigational Drugs | |
| Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclines | Cancer Medicine | |
| Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration | Annals of Surgical Oncology | |
| Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy | Breast Cancer Research and Treatment | 2022 |
| Update on Sentinel Node Pathology in Breast Cancer | Seminars in Diagnostic Pathology | 2022 |
| The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in point | Pathology | 2022 |
| Comparison of Heart and Lung Doses According to Tumor Bed Boost Techniques in Early-Stage Left-Sided Breast Cancer: Simultaneous Integrated Boost versus Sequential Boost | Medicina (Lithuania) | 2022 |
| Gynecological Cancer and Breast Cancer | | 2022 |
| Lymphedema in Cancer Patients | | 2022 |
| Aspectos clínicos y terapéuticos del carcinoma de mama metastásico triple negativo | Anales Médicos De La Asociación Médica Del Centro Médico ABC | 2022 |
| Tailoring the Omission of Radiotherapy for Early-Stage Breast Cancer Based on Tumor Biology | Seminars in Radiation Oncology | 2022 |
| The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy | Breast Cancer Research and Treatment | |
| Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience | Cancer Medicine | |
| Evolving Role of Risk Tailored Therapy in Early Stage HER2-Positive Breast Cancer: A Canadian Perspective | Current Oncology | 2022 |
| Metaplastic Matrix-Producing Carcinoma and Apocrine Lobular Carcinoma In Situ Associated with Microglandular Adenosis: A Unique Case Report | Diagnostics | 2022 |
| Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers | PLoS ONE | 2022 |
| Perioperative HER2 targeted treatment in early stage HER2-positive breast cancer | Therapeutic Advances in Medical Oncology | 2022 |
| Breast cancer | | 2023 |
| Management of triple negative breast cancer in a centenarian | Cancer Reports | |
| Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC) | Breast Cancer | |
| BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer | Cancers | 2022 |
| Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy | Breast Cancer Research and Treatment | |
| SFRP4 and CDX1 Are Predictive Genes for Extragastric Recurrence of Early Gastric Cancer after Curative Resection | Journal of Clinical Medicine | 2022 |
| What Is the Best Imaging Modality for Breast Cancer Detection in Women with a Personal History? | Academic Radiology | 2022 |
| T-DM1 after Pertuzumab plus Trastuzumab: Treatment Sequence-Induced Selection Bias in HER2-Positive Metastatic Breast Cancer | Cancers | 2022 |
| The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS. | Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin | 2022 |
| A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer. | Cancer | 2022 |
| Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib. | Annals of Oncology | 2022 |
| Culturally Sensitive Recommendations for the Clinical Pharmacist to Engage the Arab American Patient | JACCP Journal of the American College of Clinical Pharmacy | |
| Real world incidence and management of adverse events in patients with HR+, HER2- metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting. | Current Medical Research and Opinion | 2022 |
| Bone Health Considerations in Breast Cancer. | Seminars in Oncology Nursing | 2022 |
| Treatment Patterns in Women Age 80 and Over with DCIS: A Report from the National Cancer Database | Clinical Breast Cancer | 2022 |
| ASO Author Reflections: Axillary Management in Mastectomy Patients with Limited Nodal Burden. | Annals of Surgical Oncology | 2022 |
| Pharmacological Prevention and Management of Skeletal-Related Events and Bone Loss in Individuals with Cancer. | Seminars in Oncology Nursing | 2022 |
| Surgical Treatment of de novo Metastatic Breast Cancer | Current Breast Cancer Reports | |
| The role of physics in modern radiotherapy: Current advances and developments | | 2022 |
| ASO Author Reflections: Undertreatment of Early-Stage Breast Cancer in Elderly Women Undergoing Lumpectomy Without Radiotherapy Increases the Risk of Locoregional Recurrence. | Annals of Surgical Oncology | 2022 |
| Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database. | Annals of Surgical Oncology | 2022 |
| Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy. | Annals of Surgical Oncology | 2022 |
| Synthetic contrast-enhanced computed tomography generation using a deep convolutional neural network for cardiac substructure delineation in breast cancer radiation therapy: a feasibility study. | Radiation Oncology | 2022 |
| Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010-2017. | Breast Cancer Research and Treatment | 2022 |
| Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years. | Breast Cancer Research and Treatment | 2022 |
| table_1.PDF | | 2018 |
| Data_Sheet_1.pdf | | 2019 |
| Table_1.XLS | | 2018 |
| Breast-conserving surgery with whole breast radiation therapy has a subsequent lower mood disorder incidence rate than total mastectomy in early-stage breast cancer patients: a nationwide population-based longitudinal study. | Breast Cancer Research and Treatment | 2022 |
| ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla. | Annals of Surgical Oncology | 2022 |
| Partial Breast Re-Irradiation for Patients with Ipsilateral Breast Tumor Recurrence After Initial Treatment with Breast Conservation for Early Stage Breast Cancer. | Practical Radiation Oncology | 2022 |
| Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern. | Frontiers in Oncology | 2022 |
| A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles. | Breast Cancer Research and Treatment | 2022 |
| Adjuvant Versus Neoadjuvant Systemic Therapy | | 2022 |
| Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea. | Drugs - Real World Outcomes | 2021 |
| Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review. | Frontiers in Pharmacology | 2021 |
| A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer | Scientific Reports | 2021 |
| Imaging of the Axilla and Approaches to Node-Negative Versus Node-Positive Disease at Presentation | | 2022 |
| Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction. | Current Oncology Reports | 2022 |
| Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer. | Npj Breast Cancer | 2022 |
| Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor. | Npj Breast Cancer | 2022 |
| Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. | Scientific Reports | 2022 |
| Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data. | Pharmacogenomics Journal | 2022 |
| The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment. | Npj Breast Cancer | 2022 |
| Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016. | Breast Cancer Research and Treatment | 2022 |
| Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings. | Npj Breast Cancer | 2022 |
| Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer. | Cancers | 2022 |
| Impact of Dose Intensity on Pathologic Complete Response Rate in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab and Pertuzumab (TCHP). | Targeted Oncology | 2022 |
| Primary Breast Neuroendocrine Tumor. | American Surgeon | 2022 |
| Breast Cancer—Essential news of current guidelines | Memo - Magazine of European Medical Oncology | |
| Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease. | Journal of Neuro-Oncology | 2022 |
| Recaídas locorregionales tras mastectomías preservadoras y reconstrucción inmediata en mujeres con cáncer de mama | Cirugía Española | 2022 |
| The Role of the 21-Gene Recurrence Score Assay in Hormone Receptor-Positive, Node-Positive Breast Cancer: The Canadian Experience. | Current Oncology | 2022 |
| Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018. | Clinical Breast Cancer | 2022 |
| Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial. | Breast Cancer Research and Treatment | 2022 |
| Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial. | Npj Breast Cancer | 2022 |
| The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database. | Frontiers in Oncology | 2021 |
| Influence of the coronavirus disease-2019 pandemic on breast cancer treatment: A single-center experience | Saudi Surgical Journal | 2021 |
| Association between Pre-Existing Sleep Disorders and Survival Rates of Patients with Breast Cancer. | Cancers | 2022 |
| Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer. | Radiation Oncology | 2022 |
| Anti-HER2 therapy in metastatic breast cancer: many choices and future directions. | Cancer and Metastasis Reviews | 2022 |
| Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+ HER2- Early Breast Cancer. | Annals of Pharmacotherapy | 2022 |
| Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial. | Journal of Clinical Oncology | 2022 |
| Metaplastic Breast Carcinoma in a 37-Year-Old Female: A Case Report. | Cureus | 2022 |
| The efficacy of a comprehensive bone health program in maintaining bone mineral density in postmenopausal women with early-stage breast cancer treated with endocrine therapy: real-world data. | Irish Journal of Medical Science | 2022 |
| Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ. | PLoS ONE | 2022 |
| Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program. | Npj Breast Cancer | 2022 |
| Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer. | Annals of Surgical Oncology | 2022 |
| Ethical Questions of Surgical Trials | Difficult Decisions in Surgery: an Evidence-based Approach | 2022 |
| Influence of rurality on lymph node assessment among women diagnosed with ductal carcinoma in situ and treated with mastectomy, SEER 2000-2015. | Breast Cancer Research and Treatment | 2022 |
| Neoadjuvant Treatment with HER2-Targeted Therapies in HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis. | Cancers | 2022 |
| The Usefulness of Ultrasound Surveillance for Axillary Recurrence in Women With Personal History of Breast Cancer. | Journal of Breast Cancer | 2021 |
| How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort Study. | Annals of Surgical Oncology | 2022 |
| Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study. | Current Oncology | 2022 |
| Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer. | Breast Cancer Research and Treatment | 2022 |
| Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis. | BMC Cancer | 2022 |
| Ethnic disparities in Phyllodes Tumour in Aotearoa New Zealand: a retrospective review. | ANZ Journal of Surgery | 2022 |
| Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trial. | Breast | 2022 |
| Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC. | International Journal of Molecular Sciences | 2022 |
| Surgical Management of the Axilla in Node-Negative and Node-Positive Disease at Diagnosis | | 2022 |
| Clinical Value of Axillary Ultrasonography in Breast Cancer with Lymph Node Metastases | Journal of Surgical Ultrasound | 2021 |
| Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe. | Journal of Personalized Medicine | 2022 |
| Local therapy outcomes and toxicity from the (anonymized for review) trial: A phase II randomized trial of adjuvant trastuzumab emtansine vs. paclitaxel in combination with trastuzumab in women with stage I HER2-positive breast cancer. | International Journal of Radiation Oncology Biology Physics | 2022 |
| Contribution of cost to treatment nonadherence in the US breast cancer survivors: a population-based analysis. | Breast Cancer Research and Treatment | 2022 |
| The Usefulness of Ultrasound Surveillance for Axillary Recurrence in Women With Personal History of Breast Cancer | Journal of Breast Cancer | |
| Progression of Albumin-Bound Paclitaxel and SPARC Protein in Breast Cancer | Advances in Clinical Medicine | 2021 |
| Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents. | Clinical Breast Cancer | 2021 |
| Osteoporosis: Common Side Effect | Clinical Journal of Oncology Nursing | 2021 |
| Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients? | Annals of Surgical Oncology | 2021 |
| YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development | International Journal of Molecular Sciences | 2021 |
| Duration and Dose of Adjuvant Zoledronic Acid for Treatment of Early Breast Cancer | JAMA Oncology | 2021 |
| A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer | Cancers | 2021 |
| A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer | Scientific Reports | 2021 |
| The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study | Cancers | 2021 |
| qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer | Breast Cancer Research and Treatment | 2021 |
| Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature | Oncology and Therapy | 2021 |
